Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Putnam

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Clinical and Translational Science|May 31, 2021
Translational and pharmacokinetic-pharmacodynamic application for the clinical development of GDC-0334, a novel TRPA1 inhibitorPhyllis Chan, Han Ting Ding, Bianca M Liederer, et al.
Animals : an Open Access Journal From MDPI|March 13, 2025
Endangered Przewalski's Horse, <i>Equus przewalskii</i>, Cloned from Historically Cryopreserved CellsBen J Novak, Oliver A Ryder, Marlys L Houck, et al.
The Lancet. Respiratory Medicine|September 13, 2016
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trialsNicola A Hanania, Phillip Korenblat, Kenneth R Chapman, et al.
Thorax|May 24, 2015
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studiesNicola A Hanania, Michael Noonan, Jonathan Corren, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 17, 2025
Comparison of Model-Predicted and Observed Evinacumab Pharmacokinetics and Efficacy in Children Aged < 5 Years With Homozygous Familial HypercholesterolemiaSébastien Bihorel, Robert Dingman, Jeanne Mendell, et al.
Science Translational Medicine|July 4, 2014
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE productionGail M Gauvreau, Jeffrey M Harris, Louis-Philippe Boulet, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 10, 2020
A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER)Cary D Austin, Melissa Gonzalez Edick, Ronald E Ferrando, et al.
Mabs|March 29, 2012
Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administrationYanan Zheng, Devin B Tesar, Lisa Benincosa, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Clinical and Translational Science|May 31, 2021
Translational and pharmacokinetic-pharmacodynamic application for the clinical development of GDC-0334, a novel TRPA1 inhibitorPhyllis Chan, Han Ting Ding, Bianca M Liederer, et al.
Animals : an Open Access Journal From MDPI|March 13, 2025
Endangered Przewalski's Horse, <i>Equus przewalskii</i>, Cloned from Historically Cryopreserved CellsBen J Novak, Oliver A Ryder, Marlys L Houck, et al.
The Lancet. Respiratory Medicine|September 13, 2016
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trialsNicola A Hanania, Phillip Korenblat, Kenneth R Chapman, et al.
Thorax|May 24, 2015
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studiesNicola A Hanania, Michael Noonan, Jonathan Corren, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 17, 2025
Comparison of Model-Predicted and Observed Evinacumab Pharmacokinetics and Efficacy in Children Aged < 5 Years With Homozygous Familial HypercholesterolemiaSébastien Bihorel, Robert Dingman, Jeanne Mendell, et al.
Science Translational Medicine|July 4, 2014
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE productionGail M Gauvreau, Jeffrey M Harris, Louis-Philippe Boulet, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 10, 2020
A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER)Cary D Austin, Melissa Gonzalez Edick, Ronald E Ferrando, et al.
Mabs|March 29, 2012
Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administrationYanan Zheng, Devin B Tesar, Lisa Benincosa, et al.
Pageof 10